Arcturus Therapeutics Holdings (ARCT) EBIT Margin (2018 - 2026)
Arcturus Therapeutics Holdings' EBIT Margin was -863.30% in Q2 2026, down 822.25 percentage points from -41.04% a year earlier but up 540.44 percentage points from the prior quarter.
Powered by 
Analysis
Arcturus Therapeutics Holdings (ARCT) EBIT Margin (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, Arcturus Therapeutics Holdings' EBIT Margin was -348.33% through Jun 30, 2026, down 288.91 percentage points year-over-year; for FY2025, it was -92.96%, down 30.15 percentage points from FY2024.
- EBIT Margin has now declined for three consecutive years, though with a five-year change of +656.84 percentage points (FY2020 to FY2025).
- In earlier years, EBIT Margin was -62.81% in FY2024 (-15.93 pp), -46.89% in FY2023 (-52.80 pp), 5.91% in FY2022 (+1647.24 pp) and -1641.33% in FY2021 (-891.52 pp).
- Quarterly EBIT Margin has moved between -2208.49% (Q3 2021) and 75.77% (Q4 2022) over five years.
- Compared with a year earlier, EBIT Margin has declined for four straight quarters, with an average year-over-year change of -321.75 percentage points over the last eight quarters.
- The best year-over-year quarter for EBIT Margin over five years was Q2 2022 (a gain of 2603.13 percentage points); the worst was Q1 2026 (a drop of 1346.47 percentage points).
- Per Business Quant data, ARCT's EBIT Margin in the three quarters before Q2 2026 was -1403.74% (Q1 2026), -435.06% (Q4 2025) and -96.27% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 28.37% |
| 10 | Arcturus Therapeutics Holdings | 314.64 Mn | -499.48 Mn | - | -863.30% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -863.30% |
| Mar 31, 2026 | -1,403.74% |
| Dec 31, 2025 | -435.06% |
| Sep 30, 2025 | -96.27% |
| Jun 30, 2025 | -41.04% |
| Mar 31, 2025 | -57.27% |
| Dec 31, 2024 | -146.68% |
| Sep 30, 2024 | -25.76% |
| Jun 30, 2024 | -42.37% |
| Mar 31, 2024 | -80.01% |
| Dec 31, 2023 | -59.22% |
| Sep 30, 2023 | -42.79% |
| Jun 30, 2023 | -526.42% |
| Mar 31, 2023 | 18.38% |
| Dec 31, 2022 | 75.77% |
| Sep 30, 2022 | -275.32% |
| Jun 30, 2022 | -81.53% |
| Mar 31, 2022 | -960.70% |
| Dec 31, 2021 | -649.72% |
| Sep 30, 2021 | -2,208.49% |
API Access
Arcturus Therapeutics Holdings EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=ARCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "ARCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=ARCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();